ALLURION - Key Persons
Job Titles:
- Member of the Leadership Team
- SVP, International Commercial
Job Titles:
- Chief Legal Officer
- Member of the Leadership Team
Job Titles:
- Chief Financial Officer
- Member of the Leadership Team
Job Titles:
- Chief Executive Officer
- Director
- Founder
- Member of the Nominating and Corporate Governance Committee
Douglas Hudson has served as the founder, chief executive officer and a director of Noho Dental, Inc. since July 2018, and as a Director of Modern Age since October 2020. Previously, Mr. Hudson served on the Board of Directors of Relode.com from 2017 until August 2022. Mr. Hudson also served as the founder and chief executive officer of SmileDirectClub Inc. (Nasdaq: SDC) from 2013 to 2017, and as chairman and chief executive officer of Simplex Healthcare from
2007 until 2013, when it was acquired by Arriva Medical LLC. Earlier in his career, Mr. Hudson served as founder, chief executive officer and director of HearingPlanet from 1999 until 2007. Mr. Hudson received his B.S. in Organizational Behavior from Eckerd College and his M.B.A. from Vanderbilt University, and he completed the Executive Education Programs at Harvard Business School. Mr. Hudson was nominated to serve on the Allurion Board due to his experience as an entrepreneur and an executive of health care companies.
Dr. Bruce Schirmer has been on faculty at the University of Virginia since 1985 and serves as the Stephen H. Watts Professor of Surgery, the vice chair of the Department of Surgery, the division chief of general surgery and director of the surgery nutrition support service. Previously, he was the program director of surgery for 17 years.
Job Titles:
- Professor of Surgery at Harvard Medical School
Dr. Daniel B. Jones is Professor of Surgery at Harvard Medical School and Vice Chair of Surgery at the Beth Israel Deaconess Medical Center in Boston. He graduated from Cornell University and Weil Cornell Medical School. He completed residency at Washington University-Barnes Hospital where he did a fellowship at the Washington University Institute for Minimally Invasive Surgery.
Dr. Harold S Solomon specializes in internal medicine in Chestnut Hill, MA and has over 57 years of experience in the field of medicine. He graduated from Medical College of Georgia with his medical degree in 1965. He is affiliated with numerous hospitals in Massachusetts and more, including Beth Israel Deaconess Medical Center.
Job Titles:
- Medical Director of CHI Memorial 's Weight Management Center
Dr. Jaime Ponce is the medical director of CHI Memorial's Weight Management Center. He also served as the medical director of the bariatric surgery program at Hamilton Medical Center in Dalton, Georgia. Dr. Ponce received his medical degree from I.T.E.S.M. School of Medicine in Monterrey, Mexico. He completed his general surgery residency at East Tennessee State University.
Dr. John Morton is the System Lead for Surgical Quality and Bariatric Services in the Yale New Haven Health System of 6 hospitals and Vice-Chair for Quality, Division Chief for Bariatric and Minimally Invasive Surgery and Professor in the Department of Surgery at the Yale School of Medicine. He served as Chief of Bariatric and Minimally Invasive Surgery, Clinic Chief for the Bariatric and Metabolic Inter-Disciplinary Clinic and Director of Bariatric and Minimally Invasive Surgery Fellowship at Stanford University School of Medicine from 2003-2019
Job Titles:
- Founder and Partner of Personal Physicians HealthCare
Dr. Jordan Busch is a founder and partner of Personal Physicians HealthCare. He is a Diplomate of the American Board of Internal Medicine. He has appointments to the medical staff at the Beth Israel Deaconess Hospital, the Brigham and Woman's Hospital, New England Baptist Hospital, and Newton Wellesley Hospital, and a faculty appointment to Harvard Medical School as a Clinical Instructor in Medicine.
Job Titles:
- Chief of the Division of Gastroenterology
Dr. Nezam H. Afdhal is the Chief of the Division of Gastroenterology, Hepatology and Nutrition at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. Dr. Afdhal received his MD degree in 1981 from the Royal College of Surgeons in Ireland and did fellowship training at University College Dublin and at Boston University School of Medicine.
Job Titles:
- Chairman
- Member of the Board of Directors
- Member of the Nominating and Corporate Governance Committee
Dr. Omar Ishrak has been Chairman of the Compute Health Board (NYSE: CPUH)
since its inception. Dr. Ishrak also serves on the Board of Directors at Intel Corporation (Nasdaq: INTC). Dr. Ishrak was CEO of Medtronic plc (Nasdaq: MDT) from June 2011 to April 2020 and served as Executive Chairman and Chairman of the Board of Directors until he stepped down in December 2020. Dr. Ishrak served as independent Chairman of the Board of Directors of Intel Corporation from January 2020 to January 2023 (Nasdaq: INTC). Dr. Ishrak has served as a member of the Intel board since March 2017. Prior to joining Medtronic, Dr. Ishrak was President and CEO of GE Healthcare Systems. Earlier in his career, Dr. Ishrak amassed 13 years of technology development and business management experience, holding leadership positions at Diasonics Vingmed Ultrasound Ltd., and various product development and engineering positions at Philips Ultrasound Inc. He was inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2016 and was elected to the National Academy of Engineering in 2020. Dr. Ishrak serves on the Board of Directors of the Cleveland Clinic, a nonprofit academic medical center. He is also a member of the Board of Trustees of the Asia Society, a leading educational organization dedicated to promoting mutual understanding and strengthening partnerships among peoples, leaders and institutions of Asia and the United States in a global context. In addition, he is a member of the Minnesota Public Radio Board of Trustees. He earned a Bachelor of Science degree and Ph.D. in Electrical Engineering from the University of London, King's College. He is also a Fellow of King's College. Dr. Ishrak is qualified to serve on the Allurion Board based on his extensive experience on boards of various healthcare companies.
Dr. Richard I. Rothstein is the Joseph M. Huber Professor of Medicine and Chair of the Department of Medicine at the Geisel School of Medicine at Dartmouth. He is also a Professor of Surgery. Dr. Rothstein was Director of Gastroenterology Research and Director of the Gastrointestinal Motility Lab, before becoming the Section Chief of Gastroenterology and Hepatology in 1997, a position he held for 15 years. He served as the Associate Dean for Continuing Medical Education from 1993 to 2013.
Job Titles:
- Chief Executive Officer
- Co - Founder
- Member of the Board of Directors
- Member of the Leadership Team
- Member of the Nominating and Corporate Governance Committee
Shantanu Gaur founded Allurion and has served as Allurion's Chief Executive Officer and as a member of the Allurion Board since September 2009. Dr. Gaur founded Allurion while at Harvard Medical School in 2009. Dr. Gaur graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School where he was a Paul Revere Frothingham Scholar and Paul & Daisy Soros Fellow. Dr. Gaur is qualified to serve as Chief Executive Officer and director of Allurion because of his experience founding Allurion, serving as its Chief Executive Officer and serving on the Allurion Board.
Job Titles:
- Member of the Leadership Team
- SVP, RA / QA
Over nearly 25 years at Eli Lilly, Mr. Johns held many senior leadership positions, most recently as head of Global Marketing and Alliance Management for Lilly's Diabetes and Obesity Business Unit. After retiring from Eli Lilly, Mr. Johns became the Chief Operating Officer at Adipo Therapeutics, a company on the cutting edge of harnessing the power of brown adipose tissue to advance the treatment of obesity and related metabolic disorders.
Job Titles:
- Member of the Board of Directors
- Member of the Nominating and Corporate Governance Committee
- Member of the Allurion Board
Krishna K. Gupta has served as a member of the Allurion Board since January
2017. He is the founder of REMUS Capital and Romulus Capital (collectively referred to herein as "REMUS Capital"), technology-focused venture capital firms he initially founded in 2008. Mr. Gupta serves as a director on the boards of several privately held companies, including: Ceres Imaging, which provides computer vision-analytics in agriculture; Cogito, which provides voice Al for large enterprises; Cohealo, Inc., which provides equipment sharing service for health systems; Spotta, which develops smart insect and pest monitoring solutions; and ZeroCater, which provides catering technology for enterprises. He was the first investor in Ginger, which was a leader in mental health software and merged with Headspace. Mr. Gupta has also served as a member of the board of directors of Presto Automation, Inc, (Nasdaq: PRST since 2017, including as Chairman since
2022. Prior to REMUS Capital, Mr. Gupta held roles at McKinsey & Company, a management consulting firm, and JPMorgan, an investment banking firm, where he advised several Fortune 100 clients on tech M&A deals. Mr. Gupta holds B.S. degrees in materials science and engineering, as well as in management sciences, both from the Massachusetts Institute of Technology. Mr. Gupta was nominated to serve on the board of directors of Allurion due to his experience investing in technology and healthcare businesses.
Job Titles:
- Member of the Leadership Team
- VP of People
Job Titles:
- Member of the Leadership Team
- VP, People
Job Titles:
- Member of the Board of Directors
- Member of the Nominating and Corporate Governance Committee
- Member of the Allurion Board
Michael Davin has served as a member of the Allurion Board since October 2017.
Mr. Davin has also served as a director of Follica, Inc. since December 2020, as a director of Amsel Medical Corporation since August 2020, as a director of Cynosure, LLC since January 2020, and as a director of Inkbit Corporation since June 2018. Previously, Mr. Davin served as chairman, president and chief executive officer of Cynosure Inc., a publicly traded company, from 2003 until March 2017, when it was acquired by Hologic Inc. Mr. Davin received his B.S. and B.A. from Southern New Hampshire University. Mr. Davin was nominated to serve on the Allurion board due to his experience as a director of health care and technology companies, as well as his familiarity with Allurion as a director.
Job Titles:
- Member of the Nominating and Corporate Governance Committee
Milena Alberti-Perez Joined the Allurion Board of Directors as Audit Committee Chair in March of 2024. Ms. Alberti-Perez previously served as Chief Financial Officer at Getty Images (NYSE: GETY) and CFO at Penguin Random House where she oversaw a global business generating over $3 billion in annual sales. She currently serves as Chair of the Audit Committee at Digimarc Corporation (Nasdaq: DMRC) and Chair of the Finance Committee and member of the Audit Committee at Pitney Bowes (NASDAQ: PBI).
Job Titles:
- Director
- Member of the Nominating and Corporate Governance Committee
Nicholas Lewin has served as a director of Establishment Labs Holdings, Inc.
Job Titles:
- Chief Operating Officer
- Member of the Leadership Team
- Chief Operating Office
Dr. Peter W. Siersma is an internist in Williamsburg, Massachusetts and is affiliated with Cooley Dickinson Hospital. He received his medical degree from UMass Chan Medical School and has been in practice for more than 20 years.
Prof. Dr. E.M.H. Mathus-Vliegen is a Gastroenterologist and Professor in Clinical Nutrition in the Department of Gastroenterology and Hepatology at the Academic Medical Center University of Amsterdam.
Job Titles:
- Professor of Gastrointestinal Endoscopy
Prof. Dr. Peter Siersema is a Professor of Gastrointestinal Endoscopy, and is Chief, Clinical Research Bureau, at Erasmus MC in Rotterdam, the Netherlands. He is also Professor of Endoscopic Gastrointestinal Oncology at Radboud University Medical Center in Nijmegen, the Netherlands. Within his research group, Dr. Siersema has authored more than 750 peer-reviewed papers and chapters in books. He is also the Editor-in-Chief of the journal Endoscopy.
Job Titles:
- Chief Medical Officer
- Founding Partner
- Member of the Leadership Team